Global Cystoid Macular Edema Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application

Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disruption of the normal blood-retinal barrier which leads to leakage from the perifoveal retinal capillaries causing accumulation of fluid within the intracellular spaces of the retina, mainly in the outer plexiform layer. CME is of two types: pseudophakic and nonpseudophakic cystoid macular edema. Pseudophakic cystoids macular edema is when the cause of occurrence is known while nonpseudophakic is the condition where no specific clinical findings have been observed. Symptoms of cystoids macular edema are blurred or decreased central vision.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.

Market Analysis and Insights: Global Cystoid Macular Edema Market
The research report studies the Cystoid Macular Edema market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Cystoid Macular Edema market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

Global Cystoid Macular Edema Scope and Segment
The global Cystoid Macular Edema market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cystoid Macular Edema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
IOL Research Center
Rabin Medical Center
Kyushu University
Wills Eye Institute

Frequently Asked Questions